Results 241 to 250 of about 16,509,108 (311)

Risk of very serious injuries in Swedish scaffolders - What is an acceptable risk? [PDF]

Inj Epidemiol
Järvholm B, Pettersson H.
europepmc   +1 more source

Incident low‐dose quetiapine use in adults newly diagnosed with depression in primary care: A nationwide register‐based study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to investigate the incidence of low‐dose quetiapine initiation and associated factors in adults newly diagnosed with depression in primary care. Methods We obtained medication dispensing records, primary and secondary care diagnoses and employment status for antipsychotic‐naïve individuals aged 16–65 newly diagnosed with ...
Laura Purra, Heidi Taipale, Miia Tiihonen, Markku Lähteenvuo, Jari Tiihonen, Aleksi Hamina   +5 more
wiley   +1 more source

Long-term care hospitals as end-of-life care settings in South Korea: A nationwide analysis of utilization patterns and clinical trajectories. [PDF]

PLoS One
Kim H, Shin S.
europepmc   +1 more source

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source

Diagnostic delays, treatment timeliness, and patient experiences in triple-negative breast cancer: a mixed-methods study. [PDF]

Front Oncol
Mazo Canola M, Schear R, Housman LT, Backus KV, Hogea C.   +4 more
europepmc   +1 more source

The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment

British Journal of Clinical Pharmacology, EarlyView.
Background Epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR‐TKIs) have substantially improved outcomes in non‐small cell lung cancer (NSCLC); however, the development of treatment resistance remains a major clinical challenge. This study examines the association between concomitant prescriptions of H1‐antihistamines (H1AHs) and ...
Van Thuan Nguyen, Ngoc Hoang Le, Nhu Quynh Phan, Toan Trung Duong, Le Thi Anh Thu, Hsuan‐Chia Yang, Chih‐Wei Huang, Min‐Huei Hsu, Jason C. Hsu, Chien‐Tien Su, Phung‐Anh Nguyen   +10 more
wiley   +1 more source

Annual report / Northern Life Insurance 1991

, 2011
Northern Life Insurance
core  

A conceptual model of cancer care and lived experiences in adolescents and young adults with cancer: results from the multi-national European STRONG AYA project. [PDF]

Support Care Cancer
Collaço N, Sodergren S, Way K, Košir U, Cairns C, van der Graaf W, Husson O, Darlington AS.   +7 more
europepmc   +1 more source

Annual report / Northern Life Insurance 1987

, 2011
Northern Life Insurance
core  

Annual report / Northern Life Insurance 1971

, 2011
Northern Life Insurance
core